🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 15 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/05/2023 | 76,83 | 77,66 | 75,47 | 77,14 | -0,58% | 2,85% | 64.500 |
| 15/05/2023 | 76,02 | 77,85 | 74,80 | 77,59 | +2,56% | 4,01% | 74.400 |
| 12/05/2023 | 77,90 | 77,90 | 74,81 | 75,65 | -2,65% | 3,97% | 58.300 |
| 11/05/2023 | 76,63 | 77,78 | 75,97 | 77,71 | +0,15% | 2,36% | 64.000 |
| 10/05/2023 | 78,67 | 79,02 | 76,60 | 77,59 | -0,35% | 3,08% | 82.300 |
| 09/05/2023 | 77,03 | 79,00 | 76,06 | 77,86 | +0,53% | 3,82% | 82.400 |
| 08/05/2023 | 79,61 | 79,73 | 75,76 | 77,45 | -2,37% | 4,99% | 81.100 |
| 05/05/2023 | 80,00 | 85,70 | 78,54 | 79,33 | +3,42% | 8,95% | 161.300 |
| 04/05/2023 | 74,59 | 76,96 | 73,65 | 76,71 | +1,70% | 4,44% | 79.000 |
| 03/05/2023 | 75,17 | 77,04 | 75,09 | 75,43 | +1,02% | 2,59% | 65.400 |
| 02/05/2023 | 76,65 | 76,93 | 73,66 | 74,67 | -2,67% | 4,27% | 96.700 |
| 01/05/2023 | 75,45 | 77,16 | 74,69 | 76,72 | +0,48% | 3,27% | 127.500 |
| 28/04/2023 | 77,12 | 78,52 | 75,47 | 76,35 | -1,18% | 3,95% | 183.300 |
| 27/04/2023 | 77,31 | 77,96 | 75,49 | 77,26 | -0,40% | 3,19% | 98.500 |
| 26/04/2023 | 75,89 | 77,78 | 74,60 | 77,57 | +1,68% | 4,19% | 76.800 |
| 25/04/2023 | 76,61 | 77,22 | 75,89 | 76,29 | -1,27% | 1,74% | 78.700 |
| 24/04/2023 | 76,84 | 77,27 | 76,19 | 77,27 | +0,30% | 1,41% | 44.700 |
| 21/04/2023 | 76,61 | 77,77 | 76,53 | 77,04 | +0,35% | 1,62% | 50.200 |
| 20/04/2023 | 77,50 | 77,50 | 75,99 | 76,77 | -1,43% | 1,95% | 77.000 |
| 19/04/2023 | 75,63 | 77,93 | 75,26 | 77,88 | +2,19% | 3,53% | 112.800 |
| 18/04/2023 | 75,85 | 76,21 | 73,47 | 76,21 | +0,65% | 3,61% | 90.000 |
| 17/04/2023 | 74,86 | 77,06 | 74,86 | 75,72 | +1,86% | 2,94% | 68.200 |
| 14/04/2023 | 75,48 | 76,22 | 74,11 | 74,34 | -1,55% | 2,80% | 69.600 |
| 13/04/2023 | 72,27 | 76,52 | 72,07 | 75,51 | +4,88% | 6,16% | 112.500 |
| 12/04/2023 | 75,12 | 75,91 | 71,71 | 72,00 | -3,99% | 5,59% | 86.700 |
| 11/04/2023 | 72,98 | 75,00 | 72,41 | 74,99 | +2,91% | 3,55% | 72.700 |
| 10/04/2023 | 73,05 | 73,52 | 71,64 | 72,87 | -0,21% | 2,57% | 129.300 |
| 06/04/2023 | 71,45 | 73,44 | 71,45 | 73,02 | +2,67% | 2,79% | 57.200 |
| 05/04/2023 | 70,64 | 71,75 | 70,49 | 71,12 | +0,01% | 1,78% | 70.500 |
| 04/04/2023 | 71,37 | 72,21 | 69,70 | 71,11 | -0,66% | 3,52% | 97.500 |